Chang Wang, Yizhuo Wang, Haitao Wu, Shuhan Liu, Rui Xin, Ying Meng. "A phase 2 study of fruquintinib combined with sintilimab and chidamide in refractory MSS metastatic colorectal cancer: Preliminary efficacy and safety.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.2631